[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350796-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350796-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","graph-neural-network-based-risk-stratification-of-prostate-cancer-using-gene-expression-and-shap-interpretability","Graph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability","","Accurate risk stratification is essential for guiding treatment decisions and preventing overtreatment of prostate cancer, which remains among the most prevalent cancers in adult men. Using Gleason scores from biopsies, despite known biopsy risks, this study proposes an artificial intelligence framework that integrates mRNA expression profiles with functional interaction networks to classify patients into low-, medium-, and high-risk groups. A dual-branch GNN combines gene-gene interaction graphs and sample-level features, with SHAP interpretation quantifying feature contributions, and performance reported via AUCs and accuracy on a held-out test set.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/graph-neural-network-based-risk-stratification-of-prostate-cancer-using-gene-expression-and-shap-interpretability/350796/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/graph-neural-network-based-risk-stratification-of-prostate-cancer-using-gene-expression-and-shap-interpretability/350796.png","ImageObject",300,407,{"name":42,"@type":43},"acoobca","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in prostate cancer care?","Question",{"text":63,"@type":64},"It addresses accurate risk stratification to guide treatment decisions and reduce overtreatment, while avoiding reliance solely on biopsy-based Gleason scoring that carries procedural risks.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the proposed model classify prostate cancer patients?",{"text":68,"@type":64},"It integrates mRNA expression profiles with functional interaction networks, using a five-step pipeline that culminates in risk classification with a dual-branch graph neural network.",{"name":70,"@type":61,"acceptedAnswer":71},"How is model interpretability handled?",{"text":72,"@type":64},"SHAP is used to quantify the contribution of features, helping explain which biomarkers drive the model’s predictions across risk groups.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350796,1790458076,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","OPEN ACCESS  \nCitation: Pirmoradi S, Vaghefi Moghaddam S, Ardalan M, Sharifi Bonab MM, Teshnehlab M, Zununi Vahed S (2026) Graph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability. PLoS One 21(9): e0356727 .  \n[https://doi.org/10.1371/journal.pone.0356727](https://doi.org/10.1371/journal.pone.0356727)  \n[Editor:](Editor: Stanis)[ Stanis](Editor: Stanis)ł[aw Jacek Wro](aw Jacek Wro)ński, Jan Biziel University Hospital No 2 in Bydgoszcz: Szpital Uniwersytecki Nr 2 im dr Jana Biziela w Bydgoszczy, POLAND  \nReceived: February 21, 2026  \nAccepted: August 6, 2026  \nPublished: September 8, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0356727  \nCopyright: © 2026 Pirmoradi et al. This is an open access article distributed under the terms  \nRESEARCH ARTICLE  \nGraph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability  \nSaeed Pirmoradi1,2, Sevil Vaghefi Moghaddam3, Mohammadreza Ardalan4,  \nMir Mohsen Sharifi Bonab3, Mohammad Teshnehlab2*, Sepideh Zununi Vahed4*  \n1 Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran, 2 Faculty of Electronic and Computer Engineering Department, K. N. Toosi University of Technology, Tehran, Iran, 3 Clinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran, 4 Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran  \n* [sepide.zununi@gmail.com](sepide.zununi@gmail.com), [zununivahed@tbzmed.ac.ir](zununivahed@tbzmed.ac.ir) (SZV); [teshnehlab@eetd.kntu.ac.ir](teshnehlab@eetd.kntu.ac.ir) (MT)  \nAbstract  \nAccurate risk stratification is essential for guiding treatment decisions and preventing over treatment of prostate cancer, which remains one of the most prevalent cancers among adult men. While the Gleason score, obtained from prostate biopsies, is routinely used to assess tumor aggressiveness, the biopsy procedure carries risks such as pain, infection, and, in some cases, serious complications such as sepsis. In this study, we proposed an artificial intelligence-based framework that integrates mRNA expression profiles with functional interaction networks to classify prostate cancer patients into low- , medium- , and high-risk groups defined by Gleason scores. The pipeline comprised five steps: (1) data collection from The Cancer Genome Atlas (TCGA),(2) preprocessing of gene expression data,(3) two-stage feature selection to identify informative biomarkers,(4) risk classification using a dual-branch graph neural network (GNN) that combines gene-gene interaction graphs with sample-level expression features, and (5) model interpretation using SHAP to quantify feature contributions. Differentially expressed genes were identified in the High (ASPN, GMNN, PEBP4, C2, KNCK17), Medium (C2, IGSF1, ASPN, CDKN3, AMH), and Low (TNMD, VWA5B2, ST6GALNAC5, CYP3A5, PHGR1) risk groups, underscoring the molecular heterogeneity of disease progression. On an independent held-out test set, the model achieved AUCs of 0 .86, 0.88, and 0.95 for the low- , medium- , and high-risk groups, respectively, with an overall accuracy of 80% . These results suggest that combining GNN-based modeling with explainable AI can capture both global and local molecular patterns relevant to tumor aggressiveness. However, asthe model was developed and evaluated solely on the TCGA cohort, the findings should be regarded as exploratory, and external validation will be required to establish generalizability. Within these limitations, the proposed framework highlights the potential of molecular profiling and graph-based deep lea","cbCaibWXPVt44eri","https://ap.wps.com/l/cbCaibWXPVt44eri","pdf",3550816,31,"English","# Abstract\n## Risk stratification framework\n## Dual-branch GNN and SHAP interpretation\n## Differentially expressed genes and performance","[{\"question\":\"What problem does the study address in prostate cancer care?\",\"answer\":\"It addresses accurate risk stratification to guide treatment decisions and reduce overtreatment, while avoiding reliance solely on biopsy-based Gleason scoring that carries procedural risks.\"},{\"question\":\"How does the proposed model classify prostate cancer patients?\",\"answer\":\"It integrates mRNA expression profiles with functional interaction networks, using a five-step pipeline that culminates in risk classification with a dual-branch graph neural network.\"},{\"question\":\"How is model interpretability handled?\",\"answer\":\"SHAP is used to quantify the contribution of features, helping explain which biomarkers drive the model’s predictions across risk groups.\"}]","Graph neural network-based risk stratification of prostate cancer using gene expression and SHAP interpretability | PDF",1790091114,78,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8cf5062a1580aec5272f297dfd8854c.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/135ba3c51a7ced5bf6a432a59b96497d.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b437aa8b52a745c5e4661c0d869d9a57.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5046ed28e0042571e27db04301bd981e.webp",980,1268]